Nutent Therapeutics will commercialize pharmaceutical-grade products that will be differentiated through successful clinical trials across multiple therapeutic areas. These products are intended to compete with and be superior to already-available products on the market.
Mr. Becker was appointed to his current position in January, 2017 and has more than 20 years of experience in the pharmaceutical and biotechnology industry. Mr. Becker has successfully led large, medium and entrepreneurial companies to substantial growth in fiercely competitive markets. He is currently the CEO of Levolta Pharmaceuticals, a clinical-stage company with a phase III product targeting knee osteoarthritis.
Nutent Therapeutics Products provides natural and organic health products for premium quality, head-to-toe care, inside and out!
LAUNCHING Q2 2018
DISTRIBUTORS & BUSINESS PARTNERS
Nutent Therapeutics is committed to strategic growth through targeted product acquisitions and partnerships.
We are actively pursuing external opportunities including in-licensing, out-licensing, co-development and co-marketing that are aligned with our internal areas of expertise and offer significant customer value.
Nutent Therapeutics will commercialize pharmaceutical-grade products that will be differentiated through successful clinical trials across multiple therapeutic areas.